Navigation Links
UQ leads the way on complementary medicine research
Date:4/24/2008

The University of Queensland is leading the way on research into complementary medicines to make them part of mainstream medical use.

The National Institute of Complementary Medicine (NICM) has awarded $660,000 to Associate Professor Luis Vitetta to establish a NICM Collaborative Centre for Transitional Preclinical and Clinical Research in Nutraceuticals and Herbal Medicine, which aims to support complementary and alternative medicine with evidence-based research.

Australia is one of the largest per capita users of complementary medicines in the western world, Dr Vitetta said.

And as such large consumers, it is important to fully investigate the efficacy and safety of those practices and products that are not part of conventional medicine.

Such rigorous research may ultimately replace terms such as complementary medicines which covers things such as vitamins, minerals and herbal medicines and lead to their inclusion into mainstream medicine.

Dr Vitetta, from the School of Medicine, said the Centre would draw together leading expertise in both complementary and conventional medicine to achieve its goals.

What we are seeing in the community is an enhanced interest in health and specifically people wanting health advice, as the primary source of their health options, he said.

The primary role of doctors is to manage disease and its associated symptoms, but by encompassing a wider range of medicines and treatment modalities they can provide the community with a wider choice for their health needs, especially when it is based on evidence based approach that includes disease prevention advice.

We have got a profile in this area already and this new initiative will give UQ a very important presence as a central point for complementary medicine research, he said.

In other NHMRC funding, Dr Jon Adams, from UQ's School of Population Health, was awarded $450,771 in a Complementary and Alternative Medicine (CAM) Grant to look at CAM use among mid-age women across the urban-rural divide.

Two other UQ researchers from the School of Medicine have received more than $1 million under the NHMRC's General Practice Clinical Research Program.

Associate Professor Jenny Doust received $457,200 for a project to look at improving risk assessment to prevent cardiovascular disease, and Associate Professor Geoff Mitchell received $561,670 to look at different ways of supporting the needs of carers of patients with advanced cancer.


'/>"/>

Contact: Marlene McKendry
communications@uq.edu.au
61-401-996-847
Research Australia
Source:Eurekalert

Related medicine news :

1. Prostate cancer screening program leads to bigger fall in death rates than surrounding areas
2. When positive thinking leads to financial irresponsibility like compulsive gambling
3. Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
4. Eli Manning Leads March for Babies in Manhattan
5. MRI before surgery leads to better-adapted treatment for breast cancer
6. Pennsylvania Contractor Pleads Guilty to Participating in Fraud Conspiracy at New York Presbyterian Hospital
7. UCR cell biologist co-leads joint international conference on wound healing
8. Too Little Sleep Leads to Too Much Weight for Kids
9. Stem cell research leads to potential new therapy for rare blood disorder
10. Persistent Insomnia Leads to Depression in Young Adults
11. Scientists identify new leads for treating parasitic worm disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... enterprise focused entirely on patients with cancer, today announced that Lynne Malestic, RN, ... the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coalition ... muscular dystrophy, and funding for Duchenne research, participated in the April 25 U.S. ... Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott Conference Center in ...
(Date:4/29/2016)... ... 29, 2016 , ... The Society for Assisted Reproductive Technology ... required to report in vitro fertilization (IVF) delivery rates to both ... of assisted reproductive technologies in the United States. , This year, SART’s ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... The ... the workforce is aging – meaning that there is an urgent need for highly ... and interactive training solution, delivering a multi-pronged approach to train and retain care managers, ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... ReportsnReports.com adds "Pulmonary Arterial ... report that provides an overview of the PAH ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Pulmonary Arterial ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
Breaking Medicine Technology: